Relafen 750, pharmacologically known as naproxen sodium , offers a unique physiological pathway of action. From a pharmaceutical angle , it functions primarily as a non-copyrightal compound , inhibiting prostaglandin enzymes – notably COX-1 and COX-2 – to diminish swelling and temperature . The resulting decrease in hormone-like substance synth